Kentaro Kaneko Selected Research

Kentaro Kaneko Research Topics

Disease

8	Obesity 12/2022 - 01/2016
6	Body Weight (Weight, Body) 01/2022 - 01/2016
4	Inflammation (Inflammations) 01/2020 - 01/2015
3	Insulin Resistance 01/2021 - 01/2016
2	Hypersensitivity (Allergy) 01/2023 - 06/2002
2	AIDS-Related Complex (ARC) 12/2022 - 07/2022
2	Hypoxia (Hypoxemia) 08/2011 - 04/2008
1	Dyspnea (Shortness of Breath) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Anorexia 01/2023
1	Paresthesia (Dysesthesia) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Dementia (Dementias) 01/2023
1	Cognitive Dysfunction 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Hyperphagia (Overeating) 07/2022
1	Tics (Tic) 03/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Overnutrition 12/2019
1	Infections 01/2016
1	Hypothermia 12/2012
1	Pain (Aches) 12/2012
1	Hyperglycemia 02/2012
1	Type 2 Diabetes Mellitus (MODY) 02/2012
1	Neoplasms (Cancer) 08/2011
1	Retinal Diseases 04/2008
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2008
1	Eosinophilia 06/2002
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2002

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2012
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2008
4	Peptides (Polypeptides)IBA 01/2023 - 01/2020
4	LeptinIBA 01/2022 - 01/2016
2	GhrelinIBA 01/2023 - 07/2022
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2022 - 07/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2022 - 07/2022
2	psicose (D-psicose)IBA 12/2022 - 07/2022
2	Monomeric GTP-Binding ProteinsIBA 01/2021 - 01/2016
2	Insulin (Novolin)FDA Link 01/2021 - 02/2012
2	Hormones (Hormone)IBA 01/2020 - 12/2019
2	Cytotoxins (Cytolysins)IBA 03/2015 - 01/2015
2	Interleukin-1 (Interleukin 1)IBA 03/2015 - 01/2015
2	Retinaldehyde (Retinal)IBA 08/2011 - 04/2008
2	Messenger RNA (mRNA)IBA 08/2011 - 04/2008
1	methyllycaconitineIBA 01/2023
1	prolylglycineIBA 01/2023
1	valyltyrosineIBA 01/2023
1	ThermolysinIBA 01/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	Fura-2 (Fura 2)IBA 12/2022
1	Neuropeptide YIBA 07/2022
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	EndocannabinoidsIBA 01/2020
1	Nicotine FDA Link 01/2020
1	NitroreductasesIBA 01/2020
1	ProdrugsIBA 01/2020
1	OPC-67683IBA 01/2020
1	5-deazaflavinIBA 01/2020
1	Coenzymes (Enzyme Cofactors)IBA 01/2020
1	des-n-octanoyl ghrelinIBA 01/2017
1	ProstaglandinsIBA 12/2012
1	LipidsIBA 12/2012
1	soymorphin-5IBA 02/2012
1	Aquaporins (Water Channels)IBA 08/2011
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Hypoxia-Inducible Factor 1IBA 08/2011
1	Aquaporin 1IBA 04/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2002

Therapy/Procedure

2	Oral Administration 01/2023 - 02/2012
2	Therapeutics 01/2023 - 01/2020
1	Drug Tapering 01/2023